Get notified when AMIX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — The company's ability to continue as a going concern is dependent on raising additional financing, and the auditor's report includes an explanatory paragraph expressing substantial doubt.
- Nasdaq Delisting Risk (new) — The company's market value of listed securities is below the new $5 million Nasdaq minimum, risking immediate suspension and delisting if not cured within 30 business days.
Autonomix Medical files to sell up to $1.35M of stock in at-the-market offering
Filed July 31, 2026 · ~1 min read
Key Changes
-
high
Autonomix may sell up to $1.35 million of common stock through an at-the-market offering with Ladenburg as agent, at prevailing market prices.
The Offering verify on EDGAR → -
medium
Net proceeds are earmarked for working capital and general corporate purposes, with no specific allocation disclosed.
Use of Proceeds verify on EDGAR → -
high
The company currently has 971,043 shares outstanding; selling all shares at the assumed $4.57 price would increase shares outstanding by about 30% to 1,266,447.
The Offering verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Partner
Trade AMIX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify